With Treatment
Ifc Clinics is treatment facility located at 117 East State Street in the 47963 zip code in Morocco, IN that offers medication-assisted substance abuse treatment. It accepts people with co-occurring substance use and pain, seniors and older adults and adult men into its treatment service. Ifc Clinics provides suboxone prescription, naltrexone administration and buprenorphine detox to young adults and adults. Some of the treatment approaches used by Ifc Clinics consist of matrix Model and substance use counseling. Ifc Clinics also provides detox programs and offers methamphetamines detoxification, benzodiazepines detoxification and opioid detox.
Address: 117 East State Street, Morocco, IN 47963
Here are the full facility listing details on IFC Clinics in Morocco, IN:
Types of Care at Ifc Clinics
Service Settings at Ifc Clinics
Opioid Medications used in Treatment at Ifc Clinics
Type of Alcohol Use Disorder Treatment at Ifc Clinics
Type Of Treatment at Ifc Clinics
Pharmacotherapies at Ifc Clinics
Treatment Approaches at Ifc Clinics
FacilityOwnership at Ifc Clinics
Payment/Insurance/Funding Accepted at Ifc Clinics
Special Programs/ Population Groups Supported at Ifc Clinics
Assessment/Pre-treatment at Ifc Clinics
Screening & Testing at Ifc Clinics
Transitional Services at Ifc Clinics
Ancillary Services at Ifc Clinics
Other Addictions Treatment at Ifc Clinics
Detoxification at Ifc Clinics
Counseling Services and Education at Ifc Clinics
Tobacco/Screening Services at Ifc Clinics
Facility Smoking Policy at Ifc Clinics
Age Groups Accepted at Ifc Clinics
Gender Accepted at Ifc Clinics
Phone #: 219-506-4060
Call (866) 434-2077 for 24/7 help with treatment.
Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at IFC Clinics. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.
Here are some key points to consider regarding the safety of methadone treatment:
Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.
Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.
Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).
Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.
Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.
However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.
Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like IFC Clinics to conduct a thorough assessment before starting someone on methadone.